Home › NCT06408207
CGM Academy for Youth With Type 1 Diabetes
Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes
Who can join
Ages 8 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7 * T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D * Able to speak, read, and write English or Spanish * Smartphone compatible with Dexcom G6 and G7application * Ability to participate in virtual visits Exclusion Criteria: • Known history of medical adhesive allergies
About the study
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are:
* Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education? * Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education.
Participants in the intervention group will:
* receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies. * participate in four in-depth online group sessions with diabetes care and education specialists * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Participants in the comparison group will:
* receive standard education provided to all patients at CHLA * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
What is being tested
- CGM Academy (behavioral)
Sponsor: Children's Hospital Los Angeles · Participants: 90 · Started: May 1, 2025
Contact the study team
- Rebecca Barber, PhD, RN · Phone: (323) 361-1359
Official record on ClinicalTrials.gov — NCT06408207
Locations in the U.S.
| California | Children's Hospital Los Angeles, Los Angeles |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.